Tonix Pharmaceuticals Holding (TNXP) stock: insider trades, news & valuation
Health Care · Strong buyingShare price and insider trades
Tonix Pharmaceuticals Holding insider trading at a glance (Oct 9, 2026): in the past 12 months, 4 insiders bought $459K and 0 sold $0 of TNXP stock on the open market, including a cluster buy that began Jun 8, 2026.
Get emailed when insiders cluster-buy stocks like TNXP
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
TNXP insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $40K | 2 | — | 0 |
| Q2 2026 | $132K | 3 | — | 0 |
| Q1 2026 | $286K | 2 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 4 Tonix Pharmaceuticals Holding Corp. insiders reported open-market purchases totaling $459K, while 0 insiders reported sales totaling $0. The most recent cluster buy began on Jun 8, 2026, when 3 insiders bought a combined $132K. Among insiders with enough purchase history to measure, Seth Lederman (CEO) has the highest Insider Score at 24.
TNXP stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 31SEC | Seth LedermanCEO | Buy | 2,00011,005 held (+22%) | $13.79 | $28K | -47.1% | 24 |
| Aug 24SEC | Richard H BaggerDirector | Buy | 1,000new position | $12.60 | $13K | -42.1% | — |
| Jun 15SEC | Carolyn E. TaylorDirector | Buy | 1,4151,833 held (+339%) | $10.55 | $15K | -30.8% | — |
| Jun 9SEC | Seth LedermanCEO | Buy | 5,0009,005 held (+125%) | $11.79 | $59K | -38.1% | 24 |
| Jun 9SEC | Richard Newcomb StillwellDirector | Buy | 5,000new position | $11.65 | $58K | -37.3% | — |
| Apr 1SEC | Seth LedermanCEO | Buy | 5,00020,001 held (+33%) | $12.62 | $63K | -42.2% | 24 |
| Mar 18SEC | Seth LedermanCEO | Buy | 15,00015,001 held (+1500000%) | $14.89 | $223K | -51.0% | 24 |
Insiders at Tonix Pharmaceuticals Holding Corp.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Seth LedermanCEO | $373K | — | Aug 31, 2026 | 24 |
| Richard Newcomb StillwellDirector | $58K | — | Jun 9, 2026 | — |
| Carolyn E. TaylorDirector | $15K | — | Jun 15, 2026 | — |
| Richard H BaggerDirector | $13K | — | Aug 24, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
TNXP stock: common questions
Are Tonix Pharmaceuticals Holding Corp. insiders buying TNXP stock?
In the past 12 months, 4 insiders reported open-market purchases of TNXP worth $459K. The latest was CEO Seth Lederman bought $28K of TNXP at $13.79 — raises the stake by 22%.
Are Tonix Pharmaceuticals Holding Corp. insiders selling TNXP stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is TNXP's 52-week range?
Over the past year TNXP has traded between $7.28 and $22.54. It last closed at $7.30 on Oct 9, 2026.